Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Long-Term Deferred Tax (2024 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax fell 58.29% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 58.29% year-over-year, with the annual reading at $2.2 million for FY2025, 58.29% down from the prior year.
  • Long-Term Deferred Tax hit $2.2 million in Q4 2025 for Guardian Pharmacy Services, down from $4.6 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $6.0 million in Q3 2024 to a low of $2.2 million in Q4 2025.